Jun 10 FDA advisers back Alzheimer’s drug that can slow disease By Matthew Perrone, Associated Press If the agency agrees with the panel's recommendation, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. shown to convincingly slow cognitive decline and memory problems due to Alzheimer's. Continue reading
May 15 How bird flu puts workers on farms and in food processing plants at higher risk By Laura Santhanam Workers on the front lines may be handling animals and food products before they have been treated for possible bird flu contamination. Continue reading
Mar 07 Cinnamon sold at discount stores recalled due to lead content By JoNel Aleccia, Associated Press Dollar Tree and Family Dollar stores have removed the cinnamon from their store shelves, a company spokesperson said. Customers can return products to nearby stores for a refund. Continue reading
Jan 21 Watch 5:46 Lead-contaminated applesauce pouches expose issues with food safety oversight By John Yang, Andrew Corkery, Claire Mufson, Juliet Fuisz The effects of an Oct. 2023 recall of applesauce pouches with high concentrations of lead are widening, raising questions about how food reaches store shelves, who watches over it and how far that oversight extends. Helena Bottemiller Evich, founder and… Continue watching
Jan 07 Watch 6:21 Investigation raises new questions about Philips breathing devices after 2021 recall By Ali Rogin, Andrew Corkery, Harry Zahn In 2021, a widely used breathing device manufactured by Philips was the subject of a safety recall. Now, new reporting shows that the replacement machines sent out to customers might also pose dangerous problems. Ali Rogin speaks with Debbie Cenziper,… Continue watching
Dec 09 Watch 5:08 Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’ By John Yang, Claire Mufson, Harry Zahn Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale… Continue watching
Dec 08 Gene therapies for sickle cell disease approved in U.S. By Laura Ungar, Associated Press Regulators on Friday approved two new gene therapies for sickle cell disease that doctors hope can cure the painful, inherited blood disorder that afflicts mostly Black people in the United States. Continue reading
Oct 31 WATCH: Sickle cell gene therapy gets review from FDA advisory committee By Laura Ungar, Associated Press If approved, it would be the first gene therapy on the U.S. market based on CRISPR, the gene editing tool that won its inventors the Nobel Prize in 2020. Continue reading
Oct 28 Watch 6:02 Investigation finds Philips hid safety issues with its CPAP machines for years By Ali Rogin, Andrew Corkery CPAP machines help about 8 million Americans with sleep-related breathing disorders, like sleep apnea, by keeping their airways open while they sleep. But one manufacturer, Philips Respironics, is coming under fire for a critical change it made to millions of… Continue watching
Oct 28 What an FDA advisory panel’s finding that oral phenylephrine is ineffective means for cold and flu meds By Lucas A. Berenbrok, Colleen Culley, Karen Steinmetz Pater, The Conversation The ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don’t actually work. Continue reading